Tienda Elsevier

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Clínica e Investigación en Arteriosclerosis (English Edition)

Suscribe to the journal

Clínica e Investigación en Arteriosclerosis (English Edition) Most often read

Clínica e Investigación en Arteriosclerosis (English Edition)

ISSN: 2529-9123

Clínica e Investigación en Arteriosclerosis is the official journal of the Spanish Society of Arteriosclerosis, the Latinoamerican Society of Arteriosclerosis and the Iberolatinoamerican Society of Arteriosclerosis. The journal is the leading Spanish written peer-review journal in the field of arteriosclerosis and its related risk factors. The aim of the journal is primarily the promotion of knowledge and continued medical education, with a special focus in the Spanish-speaking audience, through the publication of relevant research contributions, basic and clinical, in the field and the publication of review and update articles.

See more Open Access Option

Indexed in:

Web of Science, Index Medicus/MEDLINE, Scopus, IBECS, IME, MEDES

See more

Follow us:

Subscribe:

tienda

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2024

1.9

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2024

3.7

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2024

0.502

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2024

0.694

View more metrics

Journal Information

Most often read

Vol. 37. Issue. 6

7201

Recommendations of the Spanish Arteriosclerosis Society: The diet in cardiovascular prevention - 2024 Update

Emilio Ros, Pablo Pérez-Martínez, Ramón Estruch, José López-Miranda, Cristina Soler Ferrer, Javier Delgado-Lista, Francisco Gómez-Delgado, Rosa Solà, Vicente Pascual

Clin Investig Arterioscler. 2025;37:

7201

Full text access

Open Article

Share

60

Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study

Vicente Pallarés-Carratalá, Antonio Ruiz-García, Adalberto Serrano-Cumplido, Antonio Segura Fragoso, Verónica Fernández-Pascual, Beatriz Sánchez-Sánchez, María Inmaculada Cervera-Pérez, Francisco Javier Alonso-Moreno, ... on behalf of the Investigators of the AGORA study, of the Spanish Society of Primary Care Physicians SEMERGEN Foundation

Clin Investig Arterioscler. 2025;37:

60

Share

41

Identification of new therapeutic targets related to endoplasmic reticulum stress and mitochondrial dysfunction to reduce the risk of rupture in degenerative ascending aortic aneurysm

Rafael Almendra-Pegueros, Antonio J. Barros-Membrilla, Elvira Pérez-Marlasca, Josep Julve, José Martinez-González, Cristina Rodriguez, María Galán

Clin Investig Arterioscler. 2025;37:

41

Share

39

Evidence on cardiovascular prevention with icosapent ethyl

Jose Luis Díaz-Díaz

Clin Investig Arterioscler. 2025;37 Supl 1:

39

Full text access

Open Article

Share

30

Icosapent ethyl: From the REDUCE-IT trial to clinical practice

Juan Pedro-Botet

Clin Investig Arterioscler. 2025;37 Supl 1:

30

Full text access

Open Article

Share

25

Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk

José López-Miranda

Clin Investig Arterioscler. 2025;37 Supl 1:

25

Full text access

Open Article

Share

24

Analysis of lipoprotein (a) determination in a selection of Spanish Clinical Laboratories. Batary study

Teresa Arrobas Velilla, Salomon Martin Perez, Carla Fernández Prendes, Maria Jose Castro Castro, Silvia Camos Anguila, Antonio Leon Justel

Clin Investig Arterioscler. 2025;37:

24

Full text access

Open Article

Share

24

Treatment of hypertriglyceridemia to reduce cardiovascular risk

Carlos Guijarro Hérraiz

Clin Investig Arterioscler. 2025;37 Supl 1:

24

Full text access

Open Article

Share

21

Efficiency of fixed-dose combinations of statin and ezetimibe in the treatment of hypercholesterolemia

Carlos Guijarro, Angel Diaz, Eva Moreno, Paula Gamonal, Maria Soler, Neus Vidal-Vilar, Maria Rosa Fernandez

Clin Investig Arterioscler. 2025;37:

21

Full text access

Open Article

Share

17

Cardiovascular prevention studies in a population with hypertriglyceridemia

Ovidio Muñiz-Grijalvo

Clin Investig Arterioscler. 2025;37 Supl 1:

17

Full text access

Open Article

Share

11

The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patients

Kung-Hung Lin, Nuria Amigo, Pablo Ortiz, Cristina Alonso, Alexander V. Smolensky, Deven Parmar, Naga P. Chalasani, Samer Gawrieh

Clin Investig Arterioscler. 2025;37:

11

Full text access

Open Article

Share

10

Extracellular vesicles in atherosclerosis: Current and forthcoming impact.

José A. Páramo, Ana Cenarro, Fernando Civeira, Carmen Roncal

Clin Investig Arterioscler. 2025;37:

10

Full text access

Open Article

Share

8

COPD and cardiovascular risk

Carlos Santiago Díaz, Francisco J. Medrano, N. Muñoz-Rivas, Luis Castilla Guerra, M. Belén Alonso Ortiz

Clin Investig Arterioscler. 2025;37:

8

Share

8

Diabesity and cardiovascular mortality in a prospective population cohort followed for more than 20 years

Julio A. Carbayo-Herencia, Marta Simarro Rueda, Luis Miguel Artigao Ródenas, Juan A. Divisón Garrote, Francisca Molina Escribano, Isabel Ponce García, Antonio Palazón Bru, Pilar Torres Moreno, ... on behalf of the Albacete Vascular Diseases Group (GEVA)

Clin Investig Arterioscler. 2025;37:

8

Share

7

The mechanisms underlying the cardiac effects of modified citrus pectin in obese rats with myocardial ischemia: Role of galectin-3

Sara Jiménez-González, Beatriz Delgado-Valero, Ana Romero-Miranda, Fabian Islas, María Luaces, Bunty Ramchandani, María Cuesta-Corral, Alejandro Montoro-Garrido, ... Victoria Cachofeiro

Clin Investig Arterioscler. 2025;37:

7

Full text access

Open Article

Share

6

The impact of metabolic syndrome on coronary artery severity in patients with acute myocardial infarction: A perspective from a developing country

Hai Phuong Nguyen Tran, Tai Nhat Nguyen, Kha Minh Nguyen, Sang Quang Ly, Sy Van Hoang

Clin Investig Arterioscler. 2025;37:

6

Full text access

Open Article

Share

3

Efficacy and safety of PCSK9 inhibitors in real life

Antón González-Guerrero, Eugenia Navarrete-Rouco, David Benaiges, Eva Giralt-Steinhauer, Lidia Marcos, Anna Oliveras, Lluis Recasens, Juan Pedro-Botet

Clin Investig Arterioscler. 2025;37:

3

Share

3

The complexity of cardiovascular risk in women. Descriptive review

J. Ildefonzo Arocha Rodulfo, Gestne Aure Fariñez

Clin Investig Arterioscler. 2025;37:

3

Share